Track the 株式会社デ・ウエスタン・セラピテクス研究所 stock price and the full management transaction log of the company, a listed issuer based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社デ・ウエスタン・セラピテクス研究所 has recorded 30 insider filings. Market capitalisation: €4.3bn. The latest transaction was filed on 27 January 2026 (Holding update). Among the most active insiders: Cantor Fitzgerald Europe. The full history is free.
30
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,703 of 29,057 companies
32.1
score / 100
Value
14
Quality
50
FCF yld-12%
Earn yld-15%
EV/EBITDA·
ROE-56%
Gross mgn90%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
De Western Therapeutics Institute, Inc. es una empresa japonesa centrada en la investigación y el desarrollo de terapias innovadoras en el sector de la salud y la farmacia. Su objetivo es crear soluciones terapéuticas para diversas enfermedades.